D-1436-2019 Class II Terminated
FDA drug recall D-1436-2019 was initiated by Geritrex, LLC on May 6, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported The recall status is terminated (terminated Feb 21, 2024). Affected quantity: 1536 units.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 19, 2019
- Initiation Date
- May 6, 2019
- Termination Date
- Feb 21, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1536 units
Product description
Senna (sennosides 8.8 mg) Syrup, 8 fl oz. (237 mL) bottles, Rij Pharmaceuticals Corporation 40 Commercial Avenue, Middletown, NY 10941, NDC 53807-556-08
Reason for recall
Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported
Distribution pattern
Nationwide within the United States
Code information
Lot #: 1804012, Exp. 08/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1436-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026